ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Clinical trials for ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of targeted radiation drug for tough prostate cancer
Disease control Recruiting nowThis is the first study in people testing a new drug called 225Ac-PSMA-Trillium for advanced prostate cancer that has spread and no longer responds to standard hormone treatments. The drug is designed to deliver radiation directly to prostate cancer cells. Researchers will find t…
Matched conditions: ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for tough prostate cancer: experimental drug enters human testing
Disease control Recruiting nowThis study is testing a new drug called INV-9956 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies and chemotherapy. The first part aims to find a safe dose, and the second part will look for early signs that the drug …
Matched conditions: ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC